High-Risk Cosmetic Procedures: A New Regulatory Era for England

The Government’s consultation proposes tighter regulation of high-risk cosmetic procedures in England, restricting certain treatments to appropriately qualified healthcare professionals and introducing stronger age safeguards, CQC enforcement and potential criminal sanctions.

The publication of the Department of Health & Social Care's consultation, “Restrictions on the Performance of High-Risk Cosmetic and Wellbeing Procedures in England”¹, marks what may prove to be the most significant proposed reform of England's cosmetic medicine sector since the recommendations of the Keogh Review² over a decade ago. The consultation seeks views on introducing statutory restrictions on who may perform certain high-risk cosmetic and wellbeing interventions, coupled with enhanced enforcement powers and age-related safeguards.

For insurers, clinic owners and clinicians, the proposals are significant not only because of their headline implications, but also because they offer a clear indication of the future direction of cosmetic medicine regulation in England.

Increasing Regulatory Scrutiny

The cosmetic medicine sector has experienced sustained growth over the past decade, with an increasing range of injectable, laser-based and other minimally invasive procedures being delivered outside traditional healthcare settings.  Alongside that growth, regulators, professional bodies and patient safety organisations have repeatedly highlighted the need for corresponding development of standards of training, prescribing arrangements, patient selection and management of clinical complications.

The Government's latest consultation represents a further step in that ongoing process of reform. Under the proposals, specified “high-risk” cosmetic and wellbeing procedures would only be performed by doctors, dentists and independent prescribing nurses, midwives and pharmacists. Cosmetic surgery, including liquid Brazilian butt lift (BBL) procedures, would be restricted exclusively to doctors. The proposals would also introduce a minimum age requirement of 18 years for most procedures, subject to limited exceptions involving NHS treatment or management of medical conditions. Breach of the new requirements would constitute a criminal offence, with enforcement action falling to the Care Quality Commission (CQC).

While the consultation does not seek to regulate all cosmetic treatments, it demonstrates a clear intention to strengthen statutory safeguards around procedures considered to present the greatest risk of patient harm.

Wider Regulatory Reform

The consultation should be viewed as part of a broader movement towards greater oversight of cosmetic medicine. Recent years have seen increasing professional scrutiny by regulators such as the General Medical Council (GMC), General Dental Council (GDC), Nursing and Midwifery Council (NMC) and General Pharmaceutical Council (GPhC).  Additional measures have included restrictions on the administration of dermal fillers and botulinum toxin products to under-18s³, alongside increasing regulatory and professional scrutiny of prescribing practices, informed consent⁴ and advertising standards in cosmetic medicine⁵.

The current proposals go further by introducing a statutory framework focused upon practitioner eligibility. Rather than relying primarily upon professional regulation after harm has occurred, the proposed regime seeks to restrict who can lawfully undertake certain treatments in the first place. In practical terms, this represents a significant shift towards treating cosmetic medicine as a healthcare activity requiring healthcare-level safeguards and accountability.

Medico-Legal Implications

The proposed reforms create several important medico-legal considerations. Firstly, the introduction of criminal sanctions would materially alter the risk profile of cosmetic practice. Until now, many adverse outcomes have principally involved civil negligence claims, professional disciplinary proceedings or consumer complaints. Under the proposed framework, providers could also face criminal enforcement for undertaking restricted procedures without the requisite qualifications.

Secondly, future civil claimants are likely to rely upon any statutory requirements when pursuing negligence actions. Failure to comply with legislative restrictions, qualification requirements or age-verification obligations could be advanced as evidence that a practitioner acted below the standard expected of a reasonably competent provider.

Thirdly, insurers will need to pay increasing attention to governance, clinical oversight and regulatory compliance when assessing risk. Practitioner qualifications, prescribing arrangements and quality assurance processes may become increasingly significant underwriting considerations.

Finally, the reforms are likely to reinforce the need for high standards of patient assessment, informed consent and record keeping. As cosmetic medicine becomes more closely aligned with mainstream healthcare regulation, the quality of the clinical decision-making processes will attract as much scrutiny as the technical delivery of the treatment itself.

Potential Future Areas of Litigation

Should the proposals be implemented, several emerging areas of dispute can reasonably be anticipated. Questions may arise regarding whether particular treatments fall within a restricted category and whether an individual practitioner possesses the qualifications necessary to perform them lawfully.

Clinic operators may face increasing scrutiny regarding vicarious liability. Such claims may focus not only upon treatment outcomes but also upon failures in practitioner vetting, training, supervision and governance.

Disputes may also arise concerning age verification, advertising claims, delegation of procedures and the adequacy of training provided in relation to new technologies or techniques.

The reforms may also increase scrutiny of patient selection processes.  Claimants may seek to argue that inadequate assessments of their suitability for a procedure (i.e. because of psychological vulnerability, unrealistic expectations or concerns such as body dysmorphic disorder) fundamentally contributed to inappropriate cosmetic treatments.

Comparison with Scotland and Ireland

Scotland has already moved towards a dedicated legislative framework for non-surgical cosmetic interventions through the Non-surgical Procedures and Functions of Medical Reviewers (Scotland) Act 2026. The Scottish model adopts a broader premises-based and procedural approach, creating offences relating to the provision of specified procedures to persons under 18 and the performance of those procedures outside permitted premises, together with associated enforcement powers and criminal sanctions. The legislation also gives Scottish Ministers extensive powers to introduce further requirements concerning practitioner qualifications, healthcare-professional involvement and regulatory oversight. Both jurisdictions are therefore pursuing enhanced patient protection through statutory regulation.

The situation in the Republic of Ireland is more fragmented. Cosmetic interventions remain subject to a combination of professional regulation, general healthcare legislation and regulation of premises rather than a single comprehensive statutory scheme governing who may perform high-risk cosmetic procedures. Consequently, if implemented, the English proposals may create one of the more prescriptive practitioner-based regulatory models within these jurisdictions.

Practical Compliance Priorities for Clinics

Although the final form of any legislation remains uncertain, clinics would be well advised to begin preparing now.  Providers should identify whether the “high-risk” treatments falling within the scope of the proposed restrictions are currently performed by practitioners who would remain eligible under the new framework.

Particular attention should also be given to prescribing arrangements. Clinics should review:

• remote prescribing practices;
• supervision structures;
• treatment delegation arrangements;
• clinical protocols;
• record-keeping supporting prescribing decisions.

Similar reviews of consent documentation and processes should be undertaken to ensure that they adequately address material risks and complications, alternative treatment options, patient expectations, psychological suitability and opportunities for the patient to consider the options and ask questions before proceeding.

Careful maintenance of governance systems is likely to become increasingly important. Clinics should ensure they maintain robust processes for verifying the qualifications and ongoing registration of clinicians, as well as documenting their training records and audit outcomes. Adverse incident reporting systems and maintenance of suitable investigation and complaint processes will be useful evidence when responding to CQC criminal investigations.

Practical Considerations for Insurers

The consultation also has important implications for insurers operating in the cosmetic medicine sector.  Assessment of existing underwriting assumptions will be necessary for clinics that utilise unregulated practitioners or provide “high-risk” procedures that may become restricted under future legislation.

Consideration should also be given to whether current policy terms adequately address the proposed practitioner eligibility requirements, exclusions relating to unlawful practice and notification obligations linked to CQC investigations.

Insurers may also want to explore with their insured the adequacy of their governance processes, consenting processes, incident reporting and training on the management of clinical complications following “high-risk” procedures.

Conclusion

The Government's consultation on restricting the performance of “high-risk” cosmetic procedures in England reflects a continuing trend towards increased regulation and accountability within the cosmetic medicine sector. In what form the proposals will emerge in due course remains to be seen but the direction of travel is clear. Cosmetic practice is increasingly being viewed through the lens of strict healthcare regulation and liability. For clinics, clinicians and insurers, now is the time to review governance structures, practitioner credentials, consent processes and insurance arrangements in anticipation of a more tightly regulated sector.

Clyde & Co's healthcare group is recognised for its extensive industry knowledge, offering a range of legal services covering public and private sectors as well as inquests, advocacy, professional regulation, product liability and pharmaceuticals/life sciences. Should we be able to assist you, please do contact one of our experts. 

1. Restrictions on the performance of high-risk cosmetic and wellbeing procedures in England - GOV.UK
2. Review of the Regulation of Cosmetic Interventions - GOV.UK
3. Botulinum Toxin and Cosmetic Fillers (Children) Act 2021
4. Guidance for doctors who offer cosmetic interventions - professional standards - GMC
5. Guidance on the marketing of surgical and non-surgical cosmetic procedures - ASA | CAP